Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment (vol 40, pg 6248, 2021)Dotan Moskovich,Yael Finkelshtein,Adi Alfandari,Amit Rosemarin,Tzuri Lifschytz,Avivit Weisz,Santanu Mondal,Harinarayana Ungati,Aviva Katzav,Debora Kidron,Govindasamy Mugesh,Martin Ellis, Bernard Lerer,Osnat Ashur-FabianONCOGENE（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
